Apparent protein unfolding midpoint 2026-11-05
An apparent protein unfolding midpoint is an operationally defined temperature marking the middle of an observed unfolding-associated transition. In a thermal shift assay, it is often written or . “Apparent” keeps the measured reporter transition distinct from an established reversible equilibrium melting point.[ref]
Consider a deliberately simple two-state reporter model. If is the unfolded fraction and the folded and unfolded signals are constant values , thenAt , algebra gives , provided . If the signal changes from to arbitrary units, its midpoint is units. This arithmetic identifies half-unfolding only under the stated reporter assumptions.
Real traces can have drifting baselines, irreversible changes or protein aggregation. A fitted midpoint or derivative peak must therefore be defined consistently when comparing samples. A higher apparent midpoint supports greater thermal stability under those conditions; it is not by itself a dissociation constant or proof that the protein retains biological activity.
Differential scanning fluorimetry 2026-11-05
Differential scanning fluorimetry follows fluorescence while a protein sample undergoes controlled heating. Changes associated with protein unfolding provide a transition curve and an apparent protein unfolding midpoint. Comparing matched conditions turns the method into a thermal shift assay.[ref]
In a common implementation, an environment-sensitive fluorescent dye reports changes as normally buried regions become exposed. Compare otherwise matched protein-plus-dye samples with and without a candidate ligand, rather than comparing measurements made with different buffers or heating programs. Fluorescent compound-only and dye-only controls can help diagnose reporter interference; these are proposed controls, not specific settings claimed for every published assay.
For an illustrative result, midpoints of and give a thermal shift of . The measured quantity is a change in a heating-dependent transition. An independent ligand binding or activity measurement is needed to assess the proposed molecular mechanism, as illustrated by the comparisons with isothermal titration calorimetry in the 2004 evaluation.[ref]
James M. Murphy 2026-11-05
James M. Murphy is a researcher in protein signaling and the functions of pseudokinases, kinase-like protein domains with altered residues normally associated with catalysis. In a 2014 collaborative study, James M. Murphy and colleagues developed a thermal shift assay to classify 31 pseudokinase protein domains according to their binding of nucleotides and metal ions.[ref]
A robust methodology to subclassify pseudokinases based on their nucleotide-binding properties by James M. Murphy and others. Abstract and classification results; Biochemical Journal 457, 323–334, 2014
The key distinction is between binding and chemical activity. A protein may bind ATP without efficiently transferring its phosphate group. The thermal shift assay measures changes in thermal stability associated with binding, while an ordinary kinase activity assay can register activity from a small contaminating protein kinase. The study found four binding classes, including pseudokinases with no detectable binding and others whose binding depended on metal ions. This showed why the label pseudokinase cannot substitute for testing an individual protein.[ref]
A robust methodology to subclassify pseudokinases based on their nucleotide-binding properties by James M. Murphy and others. Abstract: four nucleotide/cation-binding classes and contamination caveat; Experimental: thermal-shift assays
Jeong Ho Chang 2026-11-05
Jeong Ho Chang is a researcher in structural biology and a coauthor of a 2011 study of Xrn1, an exoribonuclease that degrades RNA from its end toward its end. The paper's contribution statement explicitly credits Chang with mutagenesis, nuclease assays and thermal shift assays, as well as shared crystallographic work.[ref]
The team combined X-ray crystallography with biochemical measurements. A defined protein construct yielded structures at resolution. Additional protein domains lay away from the active site, yet alterations in these regions affected activity. Comparisons of RNA binding, degradation and thermal stability helped separate possible explanations for a defective enzyme.[ref]
Structural and biochemical studies of the 5′→3′ exoribonuclease Xrn1 by Jeong Ho Chang and others. Results, Structure determination and Domain D1 may stabilize the N-terminal segment; Figures 5–6
One important experimental distinction is that the crystallized E178Q construct was catalytically defective; its detailed protein structure was not itself a demonstration of normal Xrn1 activity. A structural model and a functional assay supply complementary evidence.[ref]
Structural and biochemical studies of the 5′→3′ exoribonuclease Xrn1 by Jeong Ho Chang and others. Structure determination and Figure 5b: E178Q structure and essentially absent nuclease activity
For an original measurement example, suppose arbitrary units of intact RNA remain in a control and after an assay. The disappearance fraction is . That observation alone does not identify the degradation products, the processivity, or whether binding became weaker. Each requires an additional readout; the invented numbers illustrate why several assays are useful.
Jeong Ho Chang research profile at Kyungpook National University. Named profile, linked portrait and explicit listing of the 2011 Xrn1 paper
Mei-Chu Lo 2026-11-05
Mei-Chu Lo investigated experimental methods for detecting ligand binding to proteins. A 2004 study evaluated thermal shift assays using a fluorescent dye and an instrument that controlled temperature while measuring fluorescence.[ref]
Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery by Mei-Chu Lo and others. Analytical Biochemistry332, pp.153–159; Abstract and primary byline
The study compared binding estimates with isothermal titration calorimetry and examined relationships with enzyme activity assays. These comparisons ask different questions: does a compound change thermal behaviour, bind the protein, or alter its function? Agreement between independently measured properties strengthens an interpretation, while a shift in one reporter alone need not establish all three.[ref]
M. W. Pantoliano 2026-11-05
M. W. Pantoliano investigated ways to use protein thermal stability in molecular screening. A 2001 study developed automated, miniaturized thermal shift assays exploiting the coupling between ligand binding and protein unfolding.[ref]
High-density miniaturized thermal shift assays as a general strategy for drug discovery by M. W. Pantoliano and others. Journal of Biomolecular Screening6, pp.429–440; Abstract and byline
The motivating problem was scale: a new protein target may lack a convenient functional assay. Measuring its thermal response can provide a common experimental readout across many targets. This does not remove the need to test what a candidate compound actually does to the target's biological activity.[ref]
High-density miniaturized thermal shift assays as a general strategy for drug discovery by M. W. Pantoliano and others. Abstract; screening without prior functional characterization
Thermal shift assay 2026-11-05
A thermal shift assay compares a protein's temperature-dependent unfolding transition between experimental conditions, often with and without a candidate ligand. The measured shift reports altered thermal behaviour. It is commonly used to investigate ligand binding without first requiring an assay of the protein's biological activity.[ref]
High-density miniaturized thermal shift assays as a general strategy for drug discovery by M. W. Pantoliano and others. 2001, Abstract; energetic coupling and miniaturized screening
In differential scanning fluorimetry, an environment-sensitive fluorescent dye reports changes during heating. A temperature-controlled instrument measures fluorescence from matched control and compound-containing samples. The resulting apparent protein unfolding midpoint is a feature of the measured transition; it need not be a reversible equilibrium melting temperature.[ref]
Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery by Mei-Chu Lo and others. 2004, Abstract; dye-based unfolding measurement and instrument
For an invented example, suppose a consistently defined midpoint changes from in the control to with a compound. ThenThis indicates thermal stabilization under the tested conditions. It does not by itself give a room-temperature dissociation constant or establish inhibition of enzyme activity. The 2004 study compared the method with isothermal titration calorimetry and activity assays, illustrating the value of an independent readout.[ref]
Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery by Mei-Chu Lo and others. Abstract; orthogonal affinity and enzymatic-assay comparisons
Protein denaturation, protein aggregation and cleavage of peptide bonds are different events. A fluorescence trace alone must not be assumed to identify all three.
